Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 2
2010 2
2012 2
2013 1
2014 1
2017 1
2018 1
2019 4
2020 3
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.
West H, McCleod M, Hussein M, Morabito A, Rittmeyer A, Conter HJ, Kopp HG, Daniel D, McCune S, Mekhail T, Zer A, Reinmuth N, Sadiq A, Sandler A, Lin W, Ochi Lohmann T, Archer V, Wang L, Kowanetz M, Cappuzzo F. West H, et al. Among authors: conter hj. Lancet Oncol. 2019 Jul;20(7):924-937. doi: 10.1016/S1470-2045(19)30167-6. Epub 2019 May 20. Lancet Oncol. 2019. PMID: 31122901 Clinical Trial.
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial.
Jotte R, Cappuzzo F, Vynnychenko I, Stroyakovskiy D, Rodríguez-Abreu D, Hussein M, Soo R, Conter HJ, Kozuki T, Huang KC, Graupner V, Sun SW, Hoang T, Jessop H, McCleland M, Ballinger M, Sandler A, Socinski MA. Jotte R, et al. Among authors: conter hj. J Thorac Oncol. 2020 Aug;15(8):1351-1360. doi: 10.1016/j.jtho.2020.03.028. Epub 2020 Apr 14. J Thorac Oncol. 2020. PMID: 32302702 Free article. Clinical Trial.
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study.
Yu EY, Kolinsky MP, Berry WR, Retz M, Mourey L, Piulats JM, Appleman LJ, Romano E, Gravis G, Gurney H, Bögemann M, Emmenegger U, Joshua AM, Linch M, Sridhar S, Conter HJ, Laguerre B, Massard C, Li XT, Schloss C, Poehlein CH, de Bono JS. Yu EY, et al. Among authors: conter hj. Eur Urol. 2022 Jul;82(1):22-30. doi: 10.1016/j.eururo.2022.02.023. Epub 2022 Apr 6. Eur Urol. 2022. PMID: 35397952 Free article. Clinical Trial.
Management algorithms for metastatic prostate cancer.
Malone S, Shayegan B, Basappa NS, Chi K, Conter HJ, Hamilton RJ, Hotte SJ, Saad F, So AI, Park-Wyllie L, Hew H, McLeod D, Gotto G. Malone S, et al. Among authors: conter hj. Can Urol Assoc J. 2020 Feb;14(2):50-60. doi: 10.5489/cuaj.5840. Can Urol Assoc J. 2020. PMID: 31039111 Free PMC article. Review.
Trust for treatment.
Conter HJ. Conter HJ. J Cancer Educ. 2010 Sep;25(3):466-8. doi: 10.1007/s13187-009-0033-x. J Cancer Educ. 2010. PMID: 20112138
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum.
Saad F, Canil C, Finelli A, Hotte SJ, Malone S, Shayegan B, So AI, Aaron L, Basappa NS, Conter HJ, Danielson B, Gotto G, Hamilton RJ, Izard JP, Kapoor A, Kolinsky M, Lalani AA, Lattouf JB, Morash C, Morgan SC, Niazi T, Noonan KL, Ong M, Rendon RA, Sehdev S, Hew H, Park-Wyllie L, Chi KN. Saad F, et al. Among authors: conter hj. Can Urol Assoc J. 2020 Apr;14(4):E137-E149. doi: 10.5489/cuaj.6082. Epub 2019 Nov 5. Can Urol Assoc J. 2020. PMID: 31702544 Free PMC article. Review.
A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre.
Cheema PK, Iafolla MAJ, Nematollahi M, Berco F, Kaushik D, Matthews P, Raskin WR, Perdrizet KA, Dudani S, Husain J, Balcewicz M, Kuruvilla PG, Reingold SM, Conter HJ. Cheema PK, et al. Among authors: conter hj. Curr Oncol. 2022 Feb 4;29(2):869-880. doi: 10.3390/curroncol29020074. Curr Oncol. 2022. PMID: 35200573 Free PMC article.
Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.
Reaume MN, Basappa NS, Wood L, Kapoor A, Bjarnason GA, Blais N, Breau RH, Canil C, Cheung P, Conter HJ, Hotte SJ, Jeldres C, Jewett MAS, Karakiewicz PI, Kollmannsberger C, Patenaude F, So A, Soulières D, Venner P, Violette P, Zalewski P, Chappell H, North SA; Kidney Cancer Research Network of Canada. Reaume MN, et al. Among authors: conter hj. Can Urol Assoc J. 2017 Oct;11(10):310-320. doi: 10.5489/cuaj.4769. Can Urol Assoc J. 2017. PMID: 29382441 Free PMC article. No abstract available.
19 results